Should Athelas prioritize expanding its remote patient monitoring capabilities or focus on enhancing its existing blood testing technology?

Introduction

The trade-off question at hand is whether Athelas should prioritize expanding its remote patient monitoring capabilities or focus on enhancing its existing blood testing technology. This scenario involves balancing the potential for market expansion against the refinement of core technology. I'll approach this analysis by examining the current product landscape, evaluating potential impacts, and designing experiments to inform our decision-making process.

Step 1

Clarifying Questions (3 minutes)

• Context: I'm thinking Athelas is at a growth stage where both options could significantly impact the company's trajectory. Could you provide more context on our current market position and competitive landscape?

Why it matters: Helps assess the urgency and potential impact of each option. Expected answer: Mid-sized player with strong growth potential in both areas. Impact on approach: Would influence resource allocation and risk assessment.

• Business Context: Based on our current revenue model, I'm assuming blood testing is our primary revenue driver. How does remote monitoring currently contribute to our revenue, and what's the projected growth for each area?

Why it matters: Helps prioritize based on financial impact and growth potential. Expected answer: Blood testing is primary revenue, remote monitoring is growing rapidly. Impact on approach: Would affect the weight given to short-term vs. long-term gains.

• User Impact: I'm thinking our user base might have different needs and preferences regarding these two technologies. Can you share insights on user adoption rates and satisfaction levels for both blood testing and remote monitoring?

Why it matters: Ensures the decision aligns with user needs and preferences. Expected answer: High satisfaction with blood testing, growing interest in remote monitoring. Impact on approach: Would influence the focus on user experience improvements vs. new feature development.

• Technical Feasibility: Considering our current technology stack, I'm curious about the technical challenges involved in expanding remote monitoring vs. enhancing blood testing. What's our engineering team's assessment of the complexity and timeline for each option?

Why it matters: Helps evaluate the feasibility and resource requirements for each path. Expected answer: Remote monitoring expansion requires significant new development, blood testing enhancements are more incremental. Impact on approach: Would affect the timeline and resource allocation in our recommendation.

• Resource Allocation: I'm assuming we have limited resources to allocate between these two initiatives. Can you give me an idea of our current team capacity and budget constraints?

Why it matters: Ensures the recommendation is realistic and achievable within our constraints. Expected answer: Tight resources, need to prioritize one area over the other. Impact on approach: Would influence the scope and phasing of our recommendation.